Valeritas to Present at the Canaccord Medical Technologies & Diagnostic Forum
Nov 01, 2016 12:00 pm UTC| Business
BRIDGEWATER, N.J., Nov. 01, 2016 -- Valeritas Holdings, Inc. (OTCQB:VLRX) announced today that John Timberlake, President and Chief Executive Officer and Erick Lucera, Chief Financial Officer are scheduled to present at...
Nov 01, 2016 12:00 pm UTC| Business
PRINCETON JUNCTION, N.J., Nov. 01, 2016 -- A cascading string of distributed denial-of-service (DDoS) attacks—most recently taking down parts of hundreds of sites including Twitter, Netflix, Spotify, Airbnb, Reddit and...
Renowned Cardiologist Dr. Rony Shimony Joins Biotricity Board of Advisors
Nov 01, 2016 12:00 pm UTC| Business
REDWOOD CITY, Calif., Nov. 01, 2016 -- biotricity, Inc. (OTCQB:BTCY), a healthcare technology company dedicated to delivering innovative, medically relevant biometric remote monitoring solutions, has appointed Dr. Rony...
Major Breakthrough – New Patented Technology Saves Energy and Climate
Nov 01, 2016 12:00 pm UTC| Business
EAST GREENWICH, R.I., Nov. 01, 2016 -- VSquare/R announces new patented technology specifically suited to manufacturers of appliances, industrial machinery, and nearly every product that uses an AC electrical motor....
FairPoint Releases New Cloud Contact Center White Paper
Nov 01, 2016 12:00 pm UTC| Business
CHARLOTTE, N.C., Nov. 01, 2016 -- FairPoint Communications, Inc. (Nasdaq:FRP), a leading provider of advanced communications technology in northern New England, has published a white paper that examines today’s options...
Nov 01, 2016 12:00 pm UTC| Business
TEL AVIV, Israel, Nov. 01, 2016 -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive disorders, including Attention Deficit...
Nov 01, 2016 12:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Nov. 01, 2016 -- Portola Pharmaceuticals Inc.® (Nasdaq:PTLA) today announced that it has expanded its existing clinical collaboration agreement with Daiichi Sankyo to develop AndexXa™...